Slide 1: Establishing leadership in the rapidly accelerating respiratory remote digital monitoring environment
Establishing leadership in the rapidly accelerating respiratory remote digital monitoring environment MARCH 2021 CONFIDENTIAL
Slide 2: Establishing leadership in respiratory remote digital monitoring
adherium Establishing leadership in the rapidly accelerating respiratory remote digital monitoring environment Rapid evolution of telehealth & remote digital monitoring, accelerated by COVID and new reimbursement programs Well placed with strategy development beyond adherence alone, toward multi-sen
Slide 3: Unmet needs of respiratory patients present huge opportunity
opportunity Unmet needs of respiratory patients presents huge opportunity Adherium US$34b Annual preventable US healthcare cost for uncontrolled Asthma & COPD patients Future TAM9 US Asthma US COPD population2 population2 ER visits Hospitalisations Severe Uncontrolled Patients SEVERE 1.0m UNCONTROLL
Slide 4: Telehealth & remote digital management transformed in last 24 months
opportunity Telehealth & remote digital management of patients transformed in last 24 months due to introduction of reimbursement codes & impact of COVID pandemic COVID has changed expectations Reimbursement availability now on care delivery a catalyst for adoption Estimates of pre-pandemic awarenes
Slide 5: Telehealth reimbursement codes and 2021 payment rates
opportunity Telehealth & remote digital management of patients transformed in last 24 months due to introduction of reimbursement codes & the impact of COVID-19 pandemic 2021 Payment Rates 1 Provider sets patient up on a remote monitoring platform/system 2 Physiological data is captured/recorded ove
Slide 6: Opportunity to transform Adherium to lead integrated management solutions
strategy Opportunity NOW to transform Adherium to lead commercially valuable integrated management solutions respiratory digital management ecosystem evolution Sensors Portal Adherence Revenue generation Healthcare providers & payers Adherence & Technique Partner Summatix / Planet Innovation Integra
Slide 7: Positive progression with existing partners & product portfolio
strategy Positive progression with existing partners & product portfolio Existing Partners Current Portfolio Sensors Physiologically enabled sensor development progressing well (plan Phase 1 training completed increases asthma/COPD device market coverage from 56% to 80% by US Pilot Program of evalua
Slide 8: HGE Health & Monaghan Medical open up the professional market
strategy HGE Health & Monaghan Medical Corporation open up the professional market via immediate distribution capabilities into hospitals, specialist clinics & disease management providers Right time Channel Partner Existing Revenue Models Planned Future Revenue Model with Physiological Sensors Spec
Slide 9: Rapid acceleration in telehealth reflected in increased partnering opportunities
Rapid acceleration in telehealth & digital monitoring reflected in increased partnering strategy opportunities strengthening revenue stream potential with >10 ongoing commercial partnering engagements currently progressing at C suite level Partner Type Disease/Population Management Partners CDMO’s P
Slide 10: Ecosystem evolution enhances overall product proposition
Ecosystem evolution enhances overall product proposition to end clinical providers & payors strategy with multiple longitudinal data points, leverages portal platform, & extends revenue stream potential for individual & combination of assets beyond adherence alone Ecosystem Initial ecosystem of Adhe
Slide 11: Current sensor & software development and planned coverage
strategy Opportunity NOW to transform Adherium to lead commercially valuable integrated management solutions in rapidly accelerating respiratory remote digital monitoring environment Current Sensor & Software Development Planned CY H2 2020 CY H1 2021 CY H2 2021 - CY H1 2022 56% 65% 49% 80% OVERALL A
Slide 12: Business Evolution Road Map
strategy Business Evolution Road Map 1 CY Q3 2020 – Q2 2021 Initial partner model establishment/proof of concept 2 CY Q2 2021 – Q4 2021 Partner scale-up in US with revenue traction 3 CY 2022 Full expansion & platform leverage in US & ex-US Validate channel partners Scale-up of HGE & Monaghan; initia
Slide 13: Use of funds
use of funds Structure Use of Funds Shares on issue: 679,596,011 Research & Development $9.1m Available capacity: Sales & Marketing $4.0m LR 7.1 15% 101,939,401 LR 7.1A 10% 67,959,601 General & Administration $1.2m Commitments from existing shareholders Offer expenses $0.7m Agreement in principle fo
Slide 14: New highly qualified management in place
team New highly qualified management in place James Ward-Lilley Mike Motion Anne Bell Geoff Feakes Jane Lapon Chairman Executive Director & CEO Chief Financial Officer Chief Technical Officer Head of Pricing & Reimbursement - >35 years experience in medical devices - Qualified as a Chartered Account
Slide 15: Disclaimer and forward looking statement
Disclaimer and forward looking statement The material contained herein is of a general nature & has only commercial products & (vi) other risks & uncertainties related to been prepared as a presentation aid. This presentation does NOT the Company’s prospects, assets / products & business strategy. c
Slide 16: Appendices
appendices
Slide 17: CONFIDENTIAL
CONFIDENTIAL
Slide 18: Microsoft Azure cloud ecosystem for end-to-end respiratory care
Robust and Secure Microsoft Azure Cloud ecosystem enabling end-to-end management of product Respiratory Care. From Sensors on Inhaled devices through to a Digital Connected Dashboard. Delivering Physiological measures and medication usage. Payor / Provider Online Interfaces Reimbursement-compliant r
Slide 19: The Hailie Solution: Sensors
product The Hailie® Solution: Sensors Hailie® Sensor features* Audio / visual reminders on sensor or app Compatible with spacers Inhaler presence detection and identification Cap on, cap off Shake detector / duration / orientation sensor Pill crushing rotation detection, number & direction Activatio
Slide 20: The Hailie Solution Sensor Range
product The Hailie® Solution Sensor Range for Ventolin™ HFA pMDI for Advair™ HFA pMDI for Flovent™ HFA pMDI for ProAir™ HFA pMDI for Symbicort™ HFA pMDI for Bevespi Aerosphere® for Symbicort™ Turbuhaler™ for Advair™ Diskus™ / for Spiriva® HandiHaler® Flovent™ Diskus™ 20 CONFIDENTIAL
Slide 21: The Hailie Solution: Software - App
product The Hailie® Solution: Software Hailie® App features The Hailie® App for patients to track their adherence & medication use & capture clinical data which is sent in real time via our secure cloud to the physician portal Hailie® App is available in 2 formats: the Hailie® Lite App for “diagnost
Slide 22: The Hailie Solution: Software - Portal
product The Hailie® Solution: Software Hailie® Portal features The Hailie® Portal - a secure Cloud-based remote patient monitoring platform enabling remote care and management of Respiratory patients. Architected to enable Health Care Professionals to monitor & manage patient adherence & medication
Slide 23: March 2021
MARCH 2021 CONFIDENTIAL